Knowledge Express
  About Us   |   Pricing   |   FAQ   |   Contact Us   |   Cart Empty   |   Login Now
 User ID    
 Password 
     KE Subscription:
    
     eMarket Subscription:
    
Tools for Biotechnology, Pharmaceutical, Life Sciences, and Technology Transfer
A Method of Identifying Cdk5/p35 Modulators, and Possible Diagnostic or Therapeutic Uses for Neurodegenerative Diseases

Inventor: Ashok B. Kulkarni and Elias S. Utreras Puratich (NIDCR)Record Date: 11/5/2009
Last Updated: 11/5/2009

Abstract:
Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine cyclin-dependent kinase that is highly expressed in the central nervous system and controls many biological processes that impact learning and memory, as well as pain and drug addiction. Studies have indicated that abnormal Cdk5 activity may be associated with the onset of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The kinase activity of Cdk5 is turned on when it binds to one of the two proteins considered to be neuronal activators, p35 and p39.

Scientists at the NIH designed a cell-based assay to screen for p35 transcriptional regulators that work as upstream regulators of Cdk5. This technology may be useful for assessing the presence and risk of conditions associated with atypical Cdk5 kinase activity or for finding drug modulators that could be promising drug targets.

Development Status:

Early stage


Applications:
Diagnostic tool for assessing risk of conditions associated with abnormal Cdk5 kinase activity

Tool for screening Cdk5 modulators


Patent: 
HHS Reference No. E-012-2009/0 -- Research Material. Patent prosecution is not being pursued for this technology.

License: 
Available for licensing.

Collaborative Research Opportunity: The National Institute of Dental and Craniofacial Research, Laboratory of Cell and Developmental Biology, Functional Genomics Section, is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. Please contact David W. Bradley, Ph.D. at 301-402-0540 or bradleyda@nidcr.nih.gov for more information.


Address: 
National Institutes of Health
Office of Technology Transfer
6011 Executive Boulevard, Suite 325
Rockville, MD 20852
USA

Phone: 301-435-4689
Fax: 301-402-0220

E-mail:
sydnorc@mail.nih.gov

URL:
http://www.ott.niih.gov

 - Return to the Previous Page - 
 
Call 1-800-529-5337 or e-mail us for a demonstration of Knowledge Express!
Download a PDF of the Knowledge Express product fact sheet, pricing guide, or company description to learn more.
 
Pharma-Transfer Techno-L Pharmalicensing KE